Oral Factor XIa Inhibitor Cuts Post-Op VTE Risk: AXIOMATIC-TKR
The oral factor XIa inhibitor milvexian across a range of doses is associated with a lower risk of venous thromboembolism
Read more
Nebraska Woman With Blood Clots After Vaccine Still Critical
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. OMAHA, Neb. (AP) — The Nebraska
Read more
Gender-Affirming Hormones Not Tied to Thrombosis With Short-Term Use
(Reuters Health) – Transgender adolescents and young adults on gender-affirming hormone therapy don’t appear to be at increased risk of
Read more
Countries Resuming Use of AstraZeneca Vaccine After Blood Clot Investigation
(Reuters) – Many countries are resuming use of AstraZeneca’s COVID-19 vaccine after the European Medicines Agency and the World Health
Read more
ASH develops practice guidelines for venous thromboembolism
(HealthDay)—The American Society of Hematology (ASH) has developed new guidelines for the treatment of venous thromboembolism (VTE); the clinical practice
Read more